Evaluation of Topical Luliconazole Versus Salicylic Acid Peel for Management of Pityriasis Versicolor

A comparative study of topical 1 percent luliconazole cream versus 20 percent salicylic acid peel in the management of pityriasis versicolor - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103999

Enrollment

Registered

2026-02-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B360- Pityriasis versicolor

Interventions

Intervention1: Salicylic acid 20% peel: Salicylic acid 20% peel was applied on right side/ right half (depending on the site involved). The maximum quantity of salicylic acid peel that was used during

Eligibility

Inclusion criteria

Inclusion criteria: All patients coming to dermatology OPD with lesions of pityriasis versicolor

Exclusion criteria

Exclusion criteria: 1 Children below the age of 12 years 2 Any previous history of topical application or previous treatment taken 3 Pregnant and lactating female 4 Patients on any systemic and topical antifungal treatment

Design outcomes

Primary

Measure	Time frame
Proportion of lesions achieving mycological clearance (KOH negativity) at 6 weeks after treatment initiation.Timepoint: 6 weeks (after completion of 3 follow-ups)	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Sarah Rehan Hawai

MIMER Medical College and Dr BSTR Hospital Talegaon Dabhade Pune

snehalnavande@gmail.com9593873844

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026